fluorouracil has been researched along with rhenium in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Mabhouh, A; Mercer, JR | 1 |
| de Gelder, V; De Ridder, L; De Vos, F; Lambert, B; Slegers, G; Thierens, H; Van de Wiele, C | 1 |
| Bosma, TB; Lam, MG; van Rijk, PP; Zonnenberg, BA | 1 |
| Bantleon, R; Farkas, E; Kehlbach, R; Werner, M; Wiesinger, B; Wiskirchen, J | 1 |
| Chang, CH; Chen, LC; Ho, CL; Lan, KL; Lee, TW; Lee, WC; Liu, IH; Shien, JH; Ting, G; Wu, YH | 1 |
| Chang, CH; Chang, TJ; Chang, YJ; Chen, LC; Ho, CL; Hsu, CW; Lan, KL; Lee, TW; Lee, WC; Liu, IH; Ni, HC; Ting, G; Tsai, CC; Wu, YH | 1 |
| Chang, CH; Chang, YJ; Chen, LC; Hsu, CW; Lan, KL; Lee, TW; Ting, G | 1 |
1 trial(s) available for fluorouracil and rhenium
| Article | Year |
|---|---|
(188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Capecitabine; Deoxycytidine; Drug Resistance, Neoplasm; Etidronic Acid; Fluorouracil; Humans; Male; Middle Aged; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radioisotopes; Radiopharmaceuticals; Rhenium | 2009 |
6 other study(ies) available for fluorouracil and rhenium
| Article | Year |
|---|---|
188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases.
Topics: Animals; Bone Neoplasms; Diphosphonates; Female; Fluorouracil; Isotope Labeling; Mice; Mice, Inbred BALB C; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution | 2005 |
Assessment of supra-additive effects of cytotoxic drugs and low dose rate irradiation in an in vitro model for hepatocellular carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cobalt Radioisotopes; Combined Modality Therapy; Deoxycytidine; Dose-Response Relationship, Radiation; Fluorouracil; Gamma Rays; Gemcitabine; Glucose Transporter Type 1; Humans; Rhenium; Topotecan | 2006 |
Impact of rhenium-188, gemcitabine, and 5-fluorouracil on cholangiocellular carcinoma cells: an in vitro study.
Topics: Analysis of Variance; Antimetabolites, Antineoplastic; Cell Cycle; Cholangiocarcinoma; Deoxycytidine; Flow Cytometry; Fluorouracil; Gemcitabine; Humans; In Vitro Techniques; Palliative Care; Radioisotopes; Rhenium; Stents; Tumor Cells, Cultured | 2009 |
Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Bone Marrow; Colonic Neoplasms; Fluorouracil; Injections, Intravenous; Liposomes; Liver; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Radioisotopes; Rhenium; Tissue Distribution; Treatment Outcome | 2012 |
Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice.
Topics: Animals; Ascites; Fluorouracil; Injections, Intravenous; Kaplan-Meier Estimate; Liposomes; Male; Mice; Mice, Inbred BALB C; Peritoneal Neoplasms; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2011 |
Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Fluorouracil; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Radionuclide Imaging; Radiopharmaceuticals; Random Allocation; Rhenium; Xenograft Model Antitumor Assays | 2012 |